Global chemistry major Chemours Company has released its fourth-quarter and full-year 2025 financial results, highlighting strong gains in its Thermal & Specialized Solutions (TSS) segment, offset by headwinds in Advanced Performance Materials (APM).
In the fourth quarter 2025, the company's net sales reached $1.3 billion, slightly below last year, but TSS posted a record quarter with Opteon™ Refrigerants growing 37% year-over-year.
Net loss attributable to Chemours was $47 million, or $0.31 per diluted share, compared with a $11 million loss, or $0.08 per share, a year earlier. Adjusted net income was $7 million, or $0.05 per share, down from $14 million, or $0.09 per share, in the prior-year quarter. Adjusted EBITDA fell to $128 million from $168 million in the same period last year.
The company implemented a global TiO2 price increase effective December 1, 2025, and announced the January 15, 2026 sale of its former Kuan Yin TiO2 site for roughly $300 million in net proceeds.
In full-year 2025, Chemours posted $5.8 billion in net sales, flat versus 2024, with TSS driving record annual growth in Opteon Refrigerants.
The company recorded a net loss of $386 million, or $2.57 per share, compared to a $69 million net income, or $0.46 per share, in 2024. Adjusted net income totaled $143 million, or $0.95 per share, versus $179 million, or $1.19 per share, a year ago. Adjusted EBITDA came in at $742 million, slightly below last year’s $768 million.
Chemours projects consolidated net sales growth of 3–5%, adjusted EBITDA between $800 million and $900 million, and free cash flow conversion above 25%.
“Our consolidated fourth quarter results delivered robust cash flow and achieved revenue performance that met our expectations, highlighted by the continued transition to Opteon Refrigerants – concluding a record setting year for TSS.
"However, as a result of short-term cyclical end market headwinds experienced in our APM business, we elected to prioritize cash flow, leading to strong cash generation in the quarter. In connection with this approach APM incurred a sizable non-cash inventory charge and unfavorable product mix driving our consolidated Adjusted EBITDA slightly below our expected range,” said Denise Dignam, President & CEO.
“Although macroeconomic conditions remain tepid, our pricing actions have begun to take effect in TiO2, and we remain focused on executing our broader Pathway to Thrive strategy. The sale of our Kuan Yin TiO2 site, along with increased organic cash flow generation in 2026, will provide significant cash inflow in 2026.
"These actions align with our capital allocation priorities under Pathway to Thrive, specifically improving our debt profile and progressing Chemours closer to our long-term objective of net leverage below three times adjusted EBITDA across economic cycles," he added.
